Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
Applying to Vanderbilt Vaccine (VV) CRS · Nashville, Tennessee
Answer a few short questions to share with the research team.